Microdosing is the practice of taking small, sub-perceptual doses of psychedelic substances like psilocybin (magic mushrooms) or LSD. Unlike full doses that produce intense hallucinations, a microdose is subtle—just enough to enhance creativity, focus, and emotional well-being without distorting reality. This practice has gained popularity among entrepreneurs, artists, and those seeking alternative mental health treatments. While scientific research is still emerging, anecdotal reports suggest microdosing can improve mood, boost cognitive function, and promote overall well-being.
At its core, microdosing is about taking 1/10th to 1/20th of a typical psychedelic dose, usually every few days. The most commonly used substances are psilocybin, a naturally occurring psychedelic found in magic mushrooms, and LSD, a synthetic compound known for its profound effects on perception. Other substances, like mescaline from cacti or very low doses of DMT, are sometimes explored, but psilocybin and LSD remain the most studied. The goal isn’t to "trip" but rather to introduce a slight shift in perception—a gentle increase in mental clarity, emotional balance, and productivity.
At the heart of microdosing’s potential lies neuroplasticity, the brain’s remarkable ability to reorganize itself by forming new neural connections. Our brains were once thought to be relatively fixed after childhood, with little capacity for change. However, modern neuroscience has shattered this assumption, revealing that the brain remains adaptable throughout life, capable of rewiring itself in response to experiences, learning, and even trauma.
Neuroplasticity is the foundation of learning, memory, creativity, and emotional resilience. When we develop new skills, overcome adversity, or change our thought patterns, our brains forge new pathways and strengthen existing ones. Psychedelics, even in microdoses, are believed to amplify this natural process, enhancing cognitive flexibility and opening new possibilities for personal growth.
Microdosing may promote neuroplasticity by stimulating serotonin 5-HT2A receptors, which are deeply involved in mood regulation, cognition, and the brain’s ability to adapt. Activation of these receptors appears to encourage dendritic growth and synaptogenesis—meaning neurons extend their connections, forming stronger and more efficient networks. This may explain why microdosing is often linked to increased problem-solving skills, heightened creativity, and emotional healing.
A more plastic brain is one that learns faster and more effectively. When neural connections are flexible, it becomes easier to absorb new information, retain knowledge, and integrate complex ideas. This could be especially valuable for students, lifelong learners, and anyone engaged in creative or intellectually demanding work. Some microdosers report an increased ability to connect disparate concepts, leading to more innovative ideas and deeper insights.
Creativity thrives on the brain’s ability to form new connections between seemingly unrelated ideas. By fostering neuroplasticity, microdosing may enhance lateral thinking, helping individuals approach problems in novel ways. Artists, musicians, and writers often describe a heightened sense of creative flow, while entrepreneurs and engineers report that it helps them break free from rigid thought patterns and find unconventional solutions.
Emotional pain—whether from trauma, grief, or negative self-beliefs—can become deeply ingrained in the brain. When neural pathways repeatedly reinforce fear, anxiety, or depressive thought patterns, these emotional states can feel hardwired. But because psychedelics promote neuroplasticity, they may help loosen the grip of destructive patterns, allowing individuals to reprocess painful memories in a healthier way. Many microdosers report feeling a greater sense of emotional flexibility, an ability to let go of past wounds, and a newfound capacity for self-compassion and forgiveness.
Emerging research suggests that psychedelics, even in microdoses, may help re-wire the brain’s response to stress, reducing the hyperactivity of the amygdala (the brain’s fear center) and increasing connectivity between regions involved in self-awareness and emotional regulation. This could make microdosing a promising tool for conditions like PTSD, depression, and anxiety disorders.
Because addiction often results from rigid neural pathways reinforcing compulsive behaviors, increasing neuroplasticity could make it easier to break free from unhealthy patterns. Some individuals report that microdosing has helped them reduce cravings for nicotine, alcohol, or even negative behaviors like excessive social media use. While more research is needed, preliminary studies suggest that psychedelics could "reset" the brain’s reward system, making it easier to adopt healthier habits.
As we age, our brains naturally experience a decline in plasticity, which can lead to cognitive rigidity, memory loss, and degenerative conditions like Alzheimer’s or Parkinson’s disease. Some scientists believe that psychedelics—especially psilocybin and LSD—could help slow this decline by stimulating brain growth. The combination of microdosing with Lion’s Mane mushroom, which contains compounds that stimulate Nerve Growth Factor (NGF), is of particular interest in this field. This potential synergy may support long-term brain health and reduce the risk of neurodegeneration.
Despite its promise, microdosing isn’t without its risks. Since long-term studies are limited, the full effects on the brain remain unknown. Additionally, psychedelics can build tolerance quickly, meaning that overuse might reduce effectiveness. This is why structured microdosing schedules, like the Fadiman Protocol (one day on, two days off) or the Stamets Stack (four days on, three days off with Lion’s Mane and Niacin), are commonly recommended. I have also proposed the Lunar Stamets Protocol which you can read here. Individual responses to microdosing vary—some people feel a positive shift, while others experience heightened anxiety, irritability, or overstimulation. Those with a history of bipolar disorder or schizophrenia should avoid microdosing, as it may exacerbate symptoms.
Another major factor to consider is legality. In many countries, psychedelics remain illegal, though decriminalization movements are gaining traction. Places like Oregon and Colorado have legalized psilocybin for therapeutic use, and clinical research into its medical benefits is rapidly expanding.
For those interested in trying microdosing, starting with a low dose and tracking experiences in a journal is recommended. A typical microdose ranges from 0.1g to 0.3g of dried psilocybin mushrooms or 5-10 micrograms of LSD. Following a structured regimen, sourcing substances from a trusted provider, and staying mindful of personal responses can help ensure a safe and effective experience.
Microdosing isn’t a magic cure—it’s a gentle tool for self-exploration and growth. It won’t solve all problems, but for many, it provides a subtle yet powerful nudge toward greater creativity, emotional balance, and mental clarity. By promoting neuroplasticity, microdosing may help the brain become more adaptable, resilient, and open to change.
As research continues to unfold, microdosing may become one of the most accessible and profound tools for personal transformation in modern society. For now, it remains an intriguing bridge between ancient wisdom and cutting-edge neuroscience, inviting those who explore it to consider a fundamental question: What might we become if we give our minds the freedom to grow?